Embed Size (px)
DESCRIPTION
Efficacy and Safety of the Anti-PD-1 Monoclonal Antibody Pembrolizumab (MK-3475) in 411 Patients With Melanoma. Presented By Antoni Ribas at 2014 ASCO Annual Meeting. Disclosures. Presented By Antoni Ribas at 2014 ASCO Annual Meeting. - PowerPoint PPT Presentation
Citation preview
Efficacy and Safety of the Anti-PD-1 <br />Monoclonal Antibody Pembrolizumab (MK-3475) in 411 Patients With Melanoma
Presented By Antoni Ribas at 2014 ASCO Annual Meeting
Disclosures
Presented By Antoni Ribas at 2014 ASCO Annual Meeting
Pembrolizumab and Available Clinical Data: KEYNOTE-001 (NCT01295827)
Presented By Antoni Ribas at 2014 ASCO Annual Meeting
411 Patients in Melanoma Expansion Cohorts: KEYNOTE-001
Presented By Antoni Ribas at 2014 ASCO Annual Meeting
KEYNOTE-001 Eligibility Criteria
Presented By Antoni Ribas at 2014 ASCO Annual Meeting
KEYNOTE-001 Eligibility Criteria
Presented By Antoni Ribas at 2014 ASCO Annual Meeting
Baseline Characteristics (1)
Presented By Antoni Ribas at 2014 ASCO Annual Meeting
Baseline Characteristics (2)
Presented By Antoni Ribas at 2014 ASCO Annual Meeting
Summary of Exposurea and <br />Treatment-Related AEs by Prior IPI
Presented By Antoni Ribas at 2014 ASCO Annual Meeting
Treatment-Related AEs With Incidence >5%
Presented By Antoni Ribas at 2014 ASCO Annual Meeting
Immune-Mediated AEs
Presented By Antoni Ribas at 2014 ASCO Annual Meeting
Maximum Percent Change from Baseline in Tumor Sizea (Central Review, RECIST v1.1)
Presented By Antoni Ribas at 2014 ASCO Annual Meeting
Maximum Percent Change from Baseline in Tumor Sizea (Central Review, irRC)
Presented By Antoni Ribas at 2014 ASCO Annual Meeting
Confirmed ORR in Subgroups (Central Review, RECIST v1.1)
Presented By Antoni Ribas at 2014 ASCO Annual Meeting
Antitumor Activity by Prior Ipilimumab and Pembrolizumab Dose/Schedule
Presented By Antoni Ribas at 2014 ASCO Annual Meeting
Slide 16
Presented By Antoni Ribas at 2014 ASCO Annual Meeting
Kaplan-Meier Estimate of PFS per RECIST 1.1, Independent Central Review
Presented By Antoni Ribas at 2014 ASCO Annual Meeting
Kaplan-Meier Estimate of Overall Survival
Presented By Antoni Ribas at 2014 ASCO Annual Meeting
Summary
Presented By Antoni Ribas at 2014 ASCO Annual Meeting
Acknowledgments
Presented By Antoni Ribas at 2014 ASCO Annual Meeting
